App-Quantinova.ai

Brca1 Protects Vascular Smooth Muscle Cells from Oxidative Stress and Reduces Blood Pressure

Yi Pan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Hydrogen peroxide

Thoracic Aortic Disease: Does Aortic Size Correspond to Medial Degeneration?

Elsayed M Elmistekawy - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Bicuspid aortic valve

N/A

Clinical Outcomes in ST-Elevation and Myocardial Infarction Patients Treated with the Pharmacoinvasive strategy in the Ottawa STEMI Program

Michel Le May - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Tenecteplase

Cocooning of Cardiac Stem Cells Within Hydrogel Microcapsules Supplemented With Integrin-binding Proteins Promotes Cell Survival and Post Ischemic Cardiac Function

Everad Tilokee - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemic cardiomyopathy

DE-074

Clinical Factors Affecting Interpretation of Left Ventricular Fractional Anisotropy Obtained from ex-vivo Diffusion Tensor Magnetic Resonance Imaging

Cole Holmgren - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Adiponectin Protects Against Autoimmune Myocarditis by Inhibiting Toll-Like Receptor 4 Mediated Cardiac Inflammation And Injury

Sabrina Wilk - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Autoimmune Myocarditis

ICAM-1

Acute Cardiorenal Syndrome: The Prevalence of Impaired, Improved and Stable Renal Function in Patients With Acute Heart Failure

Sirisha Valupadas - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cardiorenal syndrome

N/A

Cardiac Morphology and Function Reference Values in Healthy Young Adults by Magnetic Resonance Imaging

Karine Bibeau - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

The Mdm2/p53 Pathway Preserves Normal Adult Heart Function, in vivo

Ludger Hauck - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

Tamoxifen

KvLQT1 Autoantibodies Accelerate Repolarization and Increase Susceptibility to Ventricular Tachyarrhythmias in an Experimental Model

Ange Maguy - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Impaired Activity of The Thioredoxin Reducing System Contributes to Diabetic Cardiac Disease: Evidence from Human and Experimental Studies

Richard E Gilbert - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic cardiomyopathy

Streptozotocin

In vivo TRPC3 Channel Blockade Suppresses Atrial Fibroblast Remodeling and AF Substrate in Dogs

Toyoaki Murohara - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Novel Photoreleasable Caged Angiotensin-II Analogs to Study Intracrine Pharmacology in Intact Cells

Myriam Letourneau - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Angiotensin II

TRPC3 Channels Regulate Nuclear Ca2+ in Atrial Fibrillation

Artak Tadevosyan - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Arrhythmia

Angiotensin II

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation - a RE-LY Trial Analysis

Stefan H Hohnloser - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Non-valvular atrial fibrillation

Pradax

Human Leukocyte Antigen-g Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation

Laura Tumiati - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac allograft vasculopathy

N/A

Nuclear AT1/AT2 Receptors Mediate Intracrine Angiotensin II Induced Fibrosis-related Gene Expression Changes in Atrial Fibroblasts

George Vaniotis - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Angiotensin II

Regulated Splicing of Plasma Membrane Ca2+ ATPase-4 Controls Cell Cycle Progression in Vascular Smooth Muscle Cells

Abdul Momen - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Angiology

Calcified vascular disease

N/A

Acute Coronary Syndrome without Chest Pain in Young Adults

Meytal Avgil - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

N/A

Improved In-Vivo Performance of Second Generation Cryoballoon for Pulmonary Vein Isolation

Medtronic CryoCath - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Filters

28841 Abstracts